Isothermal Nucleic Acid Amplification Technology (INAAT) - Global Market Review & Outlook 2020-2025

NEW YORK - June 29, 2020 - PRLog -- ​According to a new report by IMARC Group, the ​global isothermal nucleic acid amplification technology market grew at a CAGR of around 10% during 2014-2019. Looking forward, the market is expected to continue its moderate growth during the next five years.

Isothermal nucleic acid amplification technology (INAAT) is primarily deployed in the field of molecular biology for identifying and analyzing nucleic acids. It is majorly used for DNA, RNA, cell protein, ions, molecules, etc. INAAT offers a rapid, sensitive, and accurate diagnosis of genetic as well as infectious ailments. It provides amplicons for producing various nucleic acids that are predominantly utilized in biosensing, bioimaging, and biomedicines. Furthermore, INAAT is also used for detecting several diseases, such as influenza, HIV, tuberculosis, chlamydia, and gonorrhea (CT/NG), Hepatitis A and B, etc.

Market Trends:

The widespread of COVID-19 has led to the rapid shift from specialized laboratory equipment towards INAAT for coronavirus detection. Additionally, the high prevalence of several chronic diseases has augmented the demand for effective diagnosis and treatment procedures, which is propelling the market growth. The increasing popularity of INAAT in identifying genetically modified organisms (GMOs) is also catalyzing the market. Several technological advancements in the sector have led to the development of Recombinase Polymerase Amplification (RPA), Single Primer Isothermal Amplification (SPIA), and Strand Displacement Amplification (SDA). The rising investments in various R&D activities are anticipated to bolster the market for INAAT in the coming years.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market/requestsample

Insights on Market Segmentation:

Market Segmentation by Product:

Instruments
Reagents

Market Segmentation by Technology:

Helicase-Dependent Amplification (HDA)
Nicking Enzyme Amplification Reaction (NEAR)
Loop-Mediated Isothermal Amplification (LAMP)
Strand Displacement Amplification (SDA)
Nucleic Acid Sequence-Based Amplification (NASBA)
Transcription Mediated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Others

For more information about this report visit: https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market

Market Segmentation by Application:

Infectious Disease Diagnosis
Hepatitis
CT/NG
HIV
Influenza
Others
Blood Screening
Others

Market Segmentation by End-User:

Hospitals
Diagnostic Laboratories
Research Laboratories
Others

Market Segmentation by Region:

North America
Asia Pacific
Europe
Latin America
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, bioMérieux, BD (Becton, Dickinson and Company), Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, Ustar Biotechnologies Ltd., etc.

Contact Us

30 N Gould St
Ste R
Sheridan, WY 82801
USA
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal